Shahram Paydar1,2, Bijan Ziaeian1,2, Amirreza Dehghanian1,3, Mohsen Heidarpour1, Roshanak Alavi Moghadam1, Behnam Dalfardi4,5, Abbas Hallaj Karladani6. 1. Trauma Research Center, Shahid Rajaee (Emtiaz) Trauma Hospital, Shiraz University of Medical Sciences, Shiraz, Iran. 2. Department of General Surgery, Shiraz University of Medical Sciences, Shiraz, Iran. 3. Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. 4. Department of Internal Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. 5. Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran. 6. Department of Orthopaedics, Sahlgrenska Hospital, Göteborg University, Gothenburg, Sweden.
Abstract
Objective: This experimental work examined the healing effect and probable adverse impact of topical Prolavacid® solution (a polyhexamethylene biguanide-based wound cleanser) and topical Medihoney ointment in an animal model of cutaneous wound. Approach: We randomly divided 22 adult Sprague-Dawley rats (all were male) in two groups (n = 11): (1) those for which Prolavacid solution was poured on the skin wound surface; and (2) those animals for which Medihoney® ointment was applied to the wounds. These two agents were applied daily throughout the study period (21 days). We photographically followed the wounds' contraction with imaging performed on days 0, 7, and 21 postwounding. The histopathologic features of the healing wounds were evaluated using skin biopsies taken on days 7 and 21 postwounding. Results: The difference in mean wound surface area between two groups was not statistically significant on the examined days. Histopathological assessment indicated no statistically significant difference between the Prolavacid- and Medihoney-treated groups on days 7 and 21. We did not detect tissue necrosis following the topical application of Prolavacid solution. Innovation: This was the first study to examine the efficacy and probable adverse consequences of topical Prolavacid on cutaneous wound healing process. Conclusion: Our work showed no statistically significant difference between the efficacy of daily topical application of Prolavacid and Medihoney products on the healing process of fresh cutaneous wounds in our rat model.
Objective: This experimental work examined the healing effect and probable adverse impact of topical Prolavacid® solution (a polyhexamethylene biguanide-based wound cleanser) and topical Medihoney ointment in an animal model of cutaneous wound. Approach: We randomly divided 22 adult Sprague-Dawley rats (all were male) in two groups (n = 11): (1) those for which Prolavacid solution was poured on the skin wound surface; and (2) those animals for which Medihoney® ointment was applied to the wounds. These two agents were applied daily throughout the study period (21 days). We photographically followed the wounds' contraction with imaging performed on days 0, 7, and 21 postwounding. The histopathologic features of the healing wounds were evaluated using skin biopsies taken on days 7 and 21 postwounding. Results: The difference in mean wound surface area between two groups was not statistically significant on the examined days. Histopathological assessment indicated no statistically significant difference between the Prolavacid- and Medihoney-treated groups on days 7 and 21. We did not detect tissue necrosis following the topical application of Prolavacid solution. Innovation: This was the first study to examine the efficacy and probable adverse consequences of topical Prolavacid on cutaneous wound healing process. Conclusion: Our work showed no statistically significant difference between the efficacy of daily topical application of Prolavacid and Medihoney products on the healing process of fresh cutaneous wounds in our rat model.
Authors: Bahram Biglari; Arash Moghaddam; Kai Santos; Gisela Blaser; Axel Büchler; Gisela Jansen; Alfred Längler; Norbert Graf; Ursula Weiler; Verena Licht; Anke Strölin; Brigitta Keck; Volker Lauf; Udo Bode; Tyler Swing; Ralph Hanano; Nicolas T Schwarz; Arne Simon Journal: Int Wound J Date: 2012-04-11 Impact factor: 3.315
Authors: Werner Fabry; Carola Trampenau; Christian Bettag; Alexander E Handschin; Bernhard Lettgen; Franz-Xaver Huber; Joachim Hillmeier; Hans-Jürgen Kock Journal: Int J Hyg Environ Health Date: 2006-07-26 Impact factor: 5.840
Authors: T Eberlein; G Haemmerle; M Signer; U Gruber Moesenbacher; J Traber; M Mittlboeck; M Abel; R Strohal Journal: J Wound Care Date: 2012-01 Impact factor: 2.072
Authors: Yoram Abramov; Barbara Golden; Megan Sullivan; Sylvia M Botros; Jay-James R Miller; Adeeb Alshahrour; Roger P Goldberg; Peter K Sand Journal: Wound Repair Regen Date: 2007 Jan-Feb Impact factor: 3.617
Authors: Patrick Müller; Dagmar G Alber; Lynne Turnbull; Ralf C Schlothauer; Dee A Carter; Cynthia B Whitchurch; Elizabeth J Harry Journal: PLoS One Date: 2013-02-28 Impact factor: 3.240
Authors: Federica Leone; Melike Firlak; Kirsty Challen; Wayne Bonnefin; Barbara Onida; Karen L Wright; John G Hardy Journal: J Funct Biomater Date: 2019-11-14